The account generated false negative architect anti-hcv (0.17, 0.19, 0.19, 0.21, 0.19 s/co) results on a patient (b)(6) on (b)(6) 2019 and (b)(6) 2019 who tested nat positive and microplate method positive.No specific patient information was provided.No impact to patient management was reported.
|
An investigation was performed for the customer issue and included a review of the complaint text, a search for similar complaints, a review of trending data, a review of product quality history, and a review of product labeling.Ticket searches determined that there is a normal complaint activity for the lot and the tracking and trending report review determined that there are no related trends.Return testing was not completed as returns were not available.A review of manufacturing documents did not identify any issues.A retained kit of architect anti-hcv reagent, lot number 06031be00 was calibrated on one instrument and the calibration met instrument specifications.Two sensitivity panels and the positive control were tested, and testing met specifications.The clinical sensitivity was evaluated, and sensitivity performance is not adversely affected.Labeling was reviewed and found to be adequate.Based on all available information and abbott diagnostics' complaint investigation a product deficiency was not identified.
|